Oncology patients' and oncology nurses' views on palliative chemotherapy: A cross-sectional comparison

被引:1
作者
Shepherd, Jan [1 ]
Waller, Amy [2 ,3 ]
Sanson-Fisher, Rob [1 ,2 ,3 ]
Zdenkowski, Nicholas [1 ]
Douglas, Charles [4 ]
Clark, Katherine [5 ,6 ]
机构
[1] Univ Newcastle, Univ Dr, Callaghan, NSW 2308, Australia
[2] Univ Newcastle, Hlth Behav Res Grp, Univ Dr, Callaghan, NSW 2308, Australia
[3] Hunter Med Res Inst, Univ Dr, Callaghan, NSW 2308, Australia
[4] Univ Newcastle, Clin Eth & Hlth Law, Univ Dr, Callaghan, NSW 2308, Australia
[5] Northern Sydney Local Hlth Dist, Royal North Shore Hosp Campus,Reserve Rd, St Leonards, NSW 2065, Australia
[6] Univ Sydney, Northern Clin Sch, Royal North Shore Hosp Campus,Reserve Rd, St Leonards, NSW 2065, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
Cancer; Terminal care; Quality of life; Decision making; Oncology nursing; Patient participation; Cross-sectional studies; END-OF-LIFE; TREATMENT DECISION-MAKING; METASTATIC BREAST-CANCER; CLINICAL ONCOLOGY; AMERICAN SOCIETY; NEAR-DEATH; CARE; FAMILY; COMMUNICATION; ASSOCIATIONS;
D O I
10.1016/j.colegn.2021.02.004
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background: Palliative chemotherapy may be offered to patients with incurable cancer with the goal of extending life and improving quality of life. However, the adverse effects that may be associated with chemotherapy can negatively impact patients' quality of life. Oncology nurses have an integral role in caring for patients during the decision-making process and may understand the potential implications of treatment options being offered to patients. Objectives: (1) To compare the views of medical oncology outpatients and oncology nurses about palliative chemotherapy near the end of life. (2) To examine the reasons oncology nurses gave for choosing not to receive palliative chemotherapy. Design: Cross-sectional comparison study. Settings and participants: A total of 194 patients, aged 18 years or over with a confirmed diagnosis of cancer who were attending a medical oncology outpatient clinic for their second or subsequent appointment completed a pen and paper survey between September 2015 and January 2016. One hundred and seven nurses who were members of an oncology nursing society or employed in an oncology setting in a participating metropolitan hospital completed an online survey between May 2018 and July 2019. Outcome measures: Participants were presented with data derived from the Coping with Cancer study comparing six quality of life and care outcomes for patients who received, or did not receive, palliative chemotherapy in the last 6 months of life. Participants were asked to consider the data and indicate what option they would choose if they were in the same situation. Choices included: have chemotherapy; do not have chemotherapy; and unsure. Participating nurses were also asked to provide reasons for their choices. Results: Three-quarters of participating nurses indicted they would not have palliative chemotherapy if it was offered to them, compared to just over one-third of people with cancer (p < 0.001). The top three reasons participating nurses gave for not having palliative chemotherapy were: wanting to make the most of their remaining time; increasing the chance of dying in the location of their choice; and the limited benefit of palliative chemotherapy in the last 6 months of life. Conclusion: Nurses in this study were significantly less likely than patients to indicate a willingness to have palliative chemotherapy if they were in the last 6 months of life. Further research is needed to examine how nurses' knowledge and experience can help patients to make informed decisions about their care with the goal of achieving an end-of-life experience that best aligns with their wishes. (c) 2021 Australian College of Nursing Ltd. Published by Elsevier Ltd.
引用
收藏
页码:521 / 527
页数:7
相关论文
共 44 条
  • [1] Chemotherapeutic agents for the treatment of metastatic breast cancer: An update
    Abotaleb, Mariam
    Kubatka, Peter
    Caprnda, Martin
    Varghese, Elizabeth
    Zolakova, Barbora
    Zubor, Pavol
    Opatrilova, Radka
    Kruzliak, Peter
    Stefanicka, Patrik
    Busselberg, Dietrich
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 : 458 - 477
  • [2] [Anonymous], 2006, NAT COMP STAND REG N
  • [3] [Anonymous], 2015, NATL CONS STAT ESS E
  • [4] Beckstrand RL, 2017, DIMENS CRIT CARE NUR, V36, P264, DOI 10.1097/DCC.0000000000000252
  • [5] Oncology Nurses' Obstacles and Supportive Behaviors in End-of-Life Care: Providing Vital Family Care
    Beckstrand, Renea L.
    Collette, Joan
    Callister, Lynn
    Luthy, Karlen E.
    [J]. ONCOLOGY NURSING FORUM, 2012, 39 (05) : E398 - E406
  • [6] What Do Oncologists Say about Chemotherapy at the Very End of Life? Results from a Semiqualitative Survey
    Behl, Deepti
    Jatoi, Aminah
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2010, 13 (07) : 831 - 835
  • [7] Communication About Serious Illness Care Goals A Review and Synthesis of Best Practices
    Bernacki, Rachelle E.
    Block, Susan D.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (12) : 1994 - 2003
  • [8] Paradox of Prescribing Late Chemotherapy: Oncologists Explain
    Bluhm, Minnie
    Connell, Cathleen M.
    De Vries, Raymond G.
    Janz, Nancy K.
    Bickel, Kathleen E.
    Silveira, Maria J.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (12) : E1006 - E1014
  • [9] The role of hospital nurses in shared decision-making about life-prolonging treatment: A qualitative interview study
    Bos-van den Hoek, Danique W.
    Thode, Maureen
    Jongerden, Irene P.
    Van Laarhoven, Hanneke W. M.
    Smets, Ellen M. A.
    Tange, Dorien
    Henselmans, Inge
    Pasman, H. Roeline
    [J]. JOURNAL OF ADVANCED NURSING, 2021, 77 (01) : 296 - 307
  • [10] Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study
    Buiting, Hilde M.
    Rurup, Mette L.
    Wijsbek, Henri
    van Zuylen, Lia
    den Hartogh, Govert
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 342